Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' reply

Aliment Pharmacol Ther. 2017 Jan;45(1):186-187. doi: 10.1111/apt.13859.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • Carcinoma, Hepatocellular*
  • Hepatitis B, Chronic*
  • Humans
  • Liver Neoplasms

Substances

  • Antiviral Agents